Clinton's breakthrough drug committee: will it stifle new drug development?
B
B
Gatty
D003363:Cost Control; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence; D018166:Health Care Reform / Q000191:economics*; D012109:Research Support as Topic; D014481:United States